Mojoon publishes its whole catalogue in Chinese for readers in the United States and prices five products by a 疗程 — a course of treatment — that it never defines in days. Two of those five figures are open-ended floors with no ceiling published anywhere on the site.
What Mojoon charges
Semaglutide: $350/mo — the floor of a published range to $520 a course, billed monthly, struck through from $1,000; the seller says the price changes as the dose rises
Tirzepatide: $390/mo — the floor of a published range to $490 a course, billed monthly, struck through from $1,000
Semaglutide: $400/mo — per course, billed monthly, struck through from $900
NAD+: $290 — an open-ended floor per course, struck through from $849; this page defines no period and publishes no ceiling
Glutathione: $369 — an open-ended floor per course, struck through from $519; this page defines no period and publishes no ceiling
Mojoon is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A course of treatment is not a unit until it is defined
Every figure on the site is priced per 疗程, a course of treatment, and no page says how many days a course runs.
Its two injectable weight-loss pages add 疗程按月计算 — "the course is billed monthly" — so those rows at least carry a period.
Its NAD+ page and its glutathione page say nothing at all about the period, so those two figures buy an amount of time the reader cannot work out from the page.
Two of its five figures have a floor and no ceiling
The NAD+ and glutathione prices are printed with a plus sign after them, and no upper bound appears anywhere on either page.
What is recorded here is the floor, with the seller's silence about a maximum recorded alongside it.
Every price on the site is also a discount struck through against a higher anchor figure, and both numbers are kept rather than only the one in bold.
Its state claim is two counts, and the counts disagree
It prints 全美49州执照医生团队+50州药房执照 — a licensed-physician team in forty-nine states plus pharmacy licences in fifty.
A count is not a list, and forty-nine is not fifty, so no fifty-state coverage claim is credited here.
No state list is published anywhere on the site, which means a reader cannot check their own state against anything.
What it says about the medicine, and what it never says
Its NAD+ and glutathione product pages print 药物均来自FDA认证503B药房 — "medications all come from FDA-certified 503B pharmacies".
It publishes no compounding disclaimer of any kind, and no sentence anywhere saying that compounded medicines are not FDA-approved.
Both injectable weight-loss products are B12 blends by default, though each is named, dosed and priced as the single compound it is filed under.
Who it's for
Chinese-speaking readers who want the catalogue in the language they read.
Buyers who want the vial size and the concentration printed on a peptide product.
Readers who will ask what a course covers before they pay for one.
Shoppers who want the eligibility threshold stated before the intake starts.
Who should look elsewhere
Readers who need the supply length in days before buying.
Buyers who want an upper bound on the two open-ended prices.
Anyone who wants a written statement that compounded medicine is not FDA-approved.
Readers who want a named state list rather than two different counts.
Strengths
Publishes its whole catalogue and its prices in the language its readers use
Prints the vial size and the concentration on both peptide products
States its eligibility threshold openly on the weight-loss pages
Sells an at-home blood test as its own separate, separately priced product
Trade-offs
Prices by a course of treatment it never defines in days on its peptide pages
Two of its five figures are open-ended floors with no published ceiling
Publishes no statement that compounded medicines are not FDA-approved
Its licensed-physician count and its pharmacy-licence count are different numbers, and neither is a list
How we verified this
Read all five product pages in the language they are published in and recorded the seller's own unit, the 疗程, rather than translating it into a month.
Kept the struck-through anchor beside every discounted figure, and marked the two prices printed with a plus sign as floors with no published ceiling.
Read the physician count and the pharmacy-licence count as the two separate counts they are, and credited no coverage list from either.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, through a matcher that normalises both the query and the filed company name before comparing, with a positive and a nonsense control in the same run.
A provider to compare Mojoon against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
The site never says in days. Its two injectable weight-loss pages add 疗程按月计算 — "the course is billed monthly" — but the NAD+ and glutathione pages define no period at all.
Are the peptide prices the whole price?
No. Both are printed with a plus sign and neither page publishes a ceiling, so what is recorded here is a floor rather than a total.
Does it serve all fifty states?
It publishes two counts — a licensed-physician team in forty-nine states and pharmacy licences in fifty — and no list. Forty-nine is not fifty, so no fifty-state claim is credited here.
Is it certified?
It calls itself the first Chinese-language telehealth platform in the United States and the first LegitScript-certified telehealth platform serving minorities, and it claims prices eighty to ninety per cent below traditional pharmacies. Those are its own words. A badge on a seller's own page proves nothing about who holds it, and no seal probe was run.
Mojoon is not a paid partner; this link may earn a commission if that changes. Full disclosure.